MY104013A - Drug adsorbates. - Google Patents
Drug adsorbates.Info
- Publication number
- MY104013A MY104013A MYPI89000634A MYPI19890634A MY104013A MY 104013 A MY104013 A MY 104013A MY PI89000634 A MYPI89000634 A MY PI89000634A MY PI19890634 A MYPI19890634 A MY PI19890634A MY 104013 A MY104013 A MY 104013A
- Authority
- MY
- Malaysia
- Prior art keywords
- adsorbate
- aqueous
- adsorbates
- drug
- drug adsorbates
- Prior art date
Links
- 239000002156 adsorbate Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 235000019658 bitter taste Nutrition 0.000 abstract 1
- 239000003729 cation exchange resin Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 abstract 1
- 229960000620 ranitidine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888811167A GB8811167D0 (en) | 1988-05-11 | 1988-05-11 | Medicaments |
| GB888816185A GB8816185D0 (en) | 1988-07-07 | 1988-07-07 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY104013A true MY104013A (en) | 1993-10-30 |
Family
ID=26293879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI89000634A MY104013A (en) | 1988-05-11 | 1989-05-11 | Drug adsorbates. |
Country Status (35)
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219563A (en) * | 1988-05-11 | 1993-06-15 | Glaxo Group Limited | Drug adsorbates |
| CA2002492A1 (en) * | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| GB8904182D0 (en) * | 1989-02-23 | 1989-04-05 | Glaxo Canada | Pharmaceutical compositions |
| SE9003902D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | Solid dosage forms of a drug |
| GB8925484D0 (en) * | 1989-11-10 | 1989-12-28 | Glaxo Group Ltd | Process |
| WO1992004893A1 (en) * | 1990-09-13 | 1992-04-02 | Smithkline Beecham Corporation | Non-aqueous liquid oral suspensions |
| SE9003903D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | New pharmaceutical formulations |
| BR9107173A (pt) * | 1990-12-21 | 1993-11-16 | Richardson Vicks Inc | Complexos de medicamentos de poliamina e resina |
| US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| JP3278192B2 (ja) * | 1992-04-03 | 2002-04-30 | ロート製薬株式会社 | 徐放性液剤 |
| GB9211148D0 (en) * | 1992-05-26 | 1992-07-08 | Smithkline Beecham Plc | Novel treatment |
| GB9221414D0 (en) * | 1992-10-13 | 1992-11-25 | Glaxo Group Ltd | Pharmaceutical compositions |
| AU669952B2 (en) * | 1992-10-16 | 1996-06-27 | Glaxo Group Limited | Taste-masking compositions of ranitidine |
| RU2143896C1 (ru) * | 1993-03-05 | 2000-01-10 | Хексаль Аг | Кристаллический комплекс циклодекстрина с гидрохлоридом ранитидина, способ его получения и содержащие его фармацевтические составы |
| FI941777L (fi) * | 1993-04-16 | 1994-10-17 | Mcneil Ppc Inc | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi |
| GB9324409D0 (en) * | 1993-11-27 | 1994-01-12 | Smithkline Beecham Plc | Novel composition |
| DK171127B1 (da) * | 1994-04-22 | 1996-06-24 | Gea Farmaceutisk Fabrik As | Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk |
| US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
| RU2131264C1 (ru) * | 1996-06-04 | 1999-06-10 | Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко | Противоязвенное средство в виде таблеток и способ его получения |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| EP1020193A4 (en) * | 1997-09-30 | 2006-05-24 | Daiichi Seiyaku Co | ORAL PREPARATION |
| JP4283355B2 (ja) * | 1997-11-10 | 2009-06-24 | 久光製薬株式会社 | 薬剤用徐放化剤及びそれを含有した徐放性医薬組成物 |
| CN1278738A (zh) | 1997-11-10 | 2001-01-03 | 久光制药株式会社 | 药剂用缓释和含有该缓释剂的缓释性药物组合物 |
| RU2154469C2 (ru) * | 1998-08-10 | 2000-08-20 | Открытое акционерное общество фармацевтическая фирма "ЗДОРОВЬЕ" | Способ получения таблеток ранитидина |
| AU1513699A (en) * | 1998-08-18 | 2000-03-14 | Nikolai Borisovich Leonidov | Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same |
| US6514492B1 (en) | 1999-07-14 | 2003-02-04 | Schering-Plough Veterinary Corporation | Taste masking of oral quinolone liquid preparations using ion exchange resins |
| DK1200129T3 (da) * | 1999-07-14 | 2009-01-12 | Schering Plough Ltd | Smagsmaskering af orale, flydende quinolonfremstillinger ved anvendelse af ionbytterharpikser |
| GB9930058D0 (en) * | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| US20020031490A1 (en) * | 2000-07-27 | 2002-03-14 | Bellamy Simon Andrew | Method for preparing resinates |
| US20030099711A1 (en) * | 2001-08-29 | 2003-05-29 | David Meadows | Sustained release preparations |
| WO2003061709A1 (en) * | 2002-01-18 | 2003-07-31 | Advanced Phytonics Limited | A method for preparing resinates |
| US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
| WO2007001300A1 (en) * | 2005-06-28 | 2007-01-04 | Ucb, S.A. | Multiple active drug-resin conjugate |
| US20050142097A1 (en) * | 2003-12-29 | 2005-06-30 | Deepak Thassu | Multiple active drug resin conjugate |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| WO2007035028A1 (en) * | 2005-09-21 | 2007-03-29 | Chong Kun Dang Pharmaceutical Corp. | Novel resinate complex of s-clopidogrel and production method thereof |
| ATE536867T1 (de) | 2006-03-16 | 2011-12-15 | Tris Pharma Inc | Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen |
| CN100411626C (zh) * | 2006-08-28 | 2008-08-20 | 浙江大学 | 缓释型碘补充剂的制备方法 |
| US8287848B2 (en) | 2006-10-03 | 2012-10-16 | Tris Pharma Inc | Formulations containing an ionic mineral-ion exchange resin complex and uses thereof |
| CN100450548C (zh) * | 2006-12-22 | 2009-01-14 | 江苏奥赛康药业有限公司 | 一种波拉克林树脂组合物的口腔贴片及其制备方法 |
| AU2008311350B2 (en) * | 2007-10-11 | 2014-04-03 | Philip Morris Products S.A. | Smokeless tobacco product |
| WO2009102830A1 (en) * | 2008-02-13 | 2009-08-20 | Eurand Inc | Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
| JP5560701B2 (ja) * | 2008-12-26 | 2014-07-30 | ライオン株式会社 | ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法 |
| JP5412966B2 (ja) * | 2009-06-08 | 2014-02-12 | ライオン株式会社 | 粒状製剤 |
| US8357398B2 (en) * | 2009-10-21 | 2013-01-22 | Alitair Pharmaceuticals Inc. | Benzonatate compositions and methods of use |
| CN102138915A (zh) * | 2011-03-28 | 2011-08-03 | 于晓勇 | 一种口服药物制剂及其制备方法 |
| CN102198118B (zh) * | 2011-03-28 | 2012-08-29 | 于晓勇 | 一种治疗呕吐的口腔药物制剂及其制备方法 |
| CA2880456A1 (en) | 2012-08-15 | 2014-02-20 | Tris Pharma, Inc. | Methylphenidate extended release chewable tablet |
| US20200038376A1 (en) * | 2016-11-01 | 2020-02-06 | Johnson & Johnson Consumer Inc. | Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid |
| CN112020350A (zh) | 2018-04-27 | 2020-12-01 | 强生消费者公司 | 液体口服药物剂型 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR803638A (fr) * | 1935-06-21 | 1936-10-05 | Système de freinage pour portes coulissantes | |
| US2828207A (en) * | 1955-11-14 | 1958-03-25 | Du Pont | Fortification of feed |
| US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
| US2970053A (en) * | 1958-10-28 | 1961-01-31 | Pfizer & Co C | Oleandomycin resin adsorbate |
| US3138525A (en) * | 1961-06-16 | 1964-06-23 | Hoffmann La Roche | Castor wax-amprotropine-resin compositions |
| US3949068A (en) * | 1964-02-20 | 1976-04-06 | University Of Alabama In Birmingham Medical And Educational Foundation | Pharmaceutical compositions |
| GB1180233A (en) * | 1966-02-23 | 1970-02-04 | Jean Astruc | Modified Spiramycin |
| US3624209A (en) * | 1966-12-28 | 1971-11-30 | Bristol Myers Co | Composition for treatment of gastro-intestinal disorders |
| GB1218102A (en) * | 1968-03-15 | 1971-01-06 | Philips Nv | Improvements in medicaments comprising drug/ion-exchange resin compounds |
| JPS5146154B2 (enExample) * | 1972-05-11 | 1976-12-07 | ||
| GB1462356A (en) * | 1973-07-10 | 1977-01-26 | Beecham Group Ltd | Pharmaceutical compositions |
| JPS51125708A (en) * | 1974-07-23 | 1976-11-02 | Beecham Group Ltd | Production of betaalactam antibiotic complex |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
| GB2084580B (en) * | 1980-10-01 | 1984-07-04 | Glaxo Group Ltd | Aminoalkyl furan derivative |
| DE3264782D1 (en) * | 1981-10-16 | 1985-08-22 | Sanol Arznei Schwarz Gmbh | Medicinal formulation |
| GB8313217D0 (en) * | 1983-05-13 | 1983-06-22 | Glaxo Group Ltd | Pharmaceutical compositions |
| NZ215069A (en) * | 1985-03-01 | 1988-06-30 | Reckitt & Colmann Prod Ltd | Pharmaceutical composition with histamine h 2 -receptor antagonist |
| US4788055A (en) * | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| JPS6369038A (ja) * | 1986-09-10 | 1988-03-29 | Canon Inc | 光カ−ド記録媒体 |
| US4795641A (en) * | 1987-08-20 | 1989-01-03 | Eastman Kodak Company | Polymer blends having reverse phase morphology for controlled delivery of bioactive agents |
-
1989
- 1989-05-09 IL IL9024589A patent/IL90245A/en not_active IP Right Cessation
- 1989-05-10 NO NO891906A patent/NO175131C/no unknown
- 1989-05-10 HU HU892349A patent/HU204994B/hu not_active IP Right Cessation
- 1989-05-10 KR KR1019890006425A patent/KR890016968A/ko not_active Abandoned
- 1989-05-10 RU SU894614142A patent/RU2033155C1/ru active
- 1989-05-10 PT PT90523A patent/PT90523B/pt not_active IP Right Cessation
- 1989-05-10 LU LU87515A patent/LU87515A1/fr unknown
- 1989-05-10 IE IE152789A patent/IE60722B1/en not_active IP Right Cessation
- 1989-05-10 PH PH38630A patent/PH27612A/en unknown
- 1989-05-10 MX MX1598389A patent/MX173349B/es unknown
- 1989-05-10 JP JP1117167A patent/JP2944678B2/ja not_active Expired - Lifetime
- 1989-05-10 GB GB8910706A patent/GB2218333B/en not_active Expired - Fee Related
- 1989-05-10 FR FR8906102A patent/FR2631232B1/fr not_active Expired - Fee Related
- 1989-05-10 CA CA000599350A patent/CA1337272C/en not_active Expired - Fee Related
- 1989-05-10 PL PL27937789A patent/PL279377A1/xx unknown
- 1989-05-10 AT AT0112089A patent/AT401614B/de not_active IP Right Cessation
- 1989-05-10 FI FI892248A patent/FI92060C/fi not_active IP Right Cessation
- 1989-05-10 YU YU97189A patent/YU47674B/sh unknown
- 1989-05-10 SE SE8901671A patent/SE508343C2/sv not_active IP Right Cessation
- 1989-05-10 DE DE3915347A patent/DE3915347C2/de not_active Expired - Fee Related
- 1989-05-10 DK DK229489A patent/DK168934B1/da not_active IP Right Cessation
- 1989-05-10 IT IT8947938A patent/IT1232831B/it active
- 1989-05-10 GR GR890100314A patent/GR1000358B/el unknown
- 1989-05-10 NZ NZ229064A patent/NZ229064A/en unknown
- 1989-05-10 BE BE8900501A patent/BE1002159A5/fr active
- 1989-05-10 CH CH1752/89A patent/CH679011A5/fr not_active IP Right Cessation
- 1989-05-10 ES ES8901601A patent/ES2011573A6/es not_active Expired - Lifetime
- 1989-05-10 CN CN89103232A patent/CN1027133C/zh not_active Expired - Fee Related
- 1989-05-10 US US07/349,999 patent/US5032393A/en not_active Expired - Fee Related
- 1989-05-10 AU AU34617/89A patent/AU624613B2/en not_active Ceased
- 1989-05-11 NL NL8901188A patent/NL8901188A/nl active Search and Examination
- 1989-05-11 MY MYPI89000634A patent/MY104013A/en unknown
-
1994
- 1994-04-08 SG SG48194A patent/SG48194G/en unknown
- 1994-05-05 HK HK45094A patent/HK45094A/xx not_active IP Right Cessation
-
1995
- 1995-06-28 HU HU95P/P00512P patent/HU211592A9/hu unknown
- 1995-10-20 CY CY178195A patent/CY1781A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK45094A (en) | Ranitidine resin adsorbates | |
| ZA894728B (en) | A new pharmaceutical formulation as well as a process for its preparation | |
| CA2061917A1 (en) | Pediatric effervescent dosage form | |
| IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
| ES2009915A6 (es) | Un procedimiento para preparar una composicion que comprende cefuroximo-axetil en forma de particulas. | |
| PT93877A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao oral de medicamentos, por exemplo antibioticos beta-lactamicos | |
| AU2454788A (en) | N-substituted derivatives of 1-desoxynojirimycin 1- desoxymannojirimycin, processes for their preparation and their use in medicaments | |
| AU6509186A (en) | Therapeutic compositions | |
| IE812232L (en) | Composition | |
| PT85829A (en) | Therapeutic agents | |
| PH25173A (en) | Pharmaceutical composition | |
| NZ230868A (en) | Dihydroartemisinin derivatives, preparation and pharmaceutical compositions thereof | |
| GR3001185T3 (en) | Stable solid pharmaceutical composition containing ibuprofen and codeine | |
| IT1217445B (it) | Composizione farmaceutiche orosolubili contenti acetilcisteina | |
| NZ222110A (en) | Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder | |
| AU2228888A (en) | Aqueous pharmaceutical preparation for oral administration | |
| IE37378B1 (en) | Taste-improving formulations of oral penicillins | |
| CA2024505A1 (en) | Dosage form for delivering soluble or insoluble drugs | |
| IL95444A0 (en) | (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents,their preparation and pharmaceutical compositions containing them | |
| IL86411A (en) | Catecholamine derivatives,their preparation and pharmaceutical compositions containing them | |
| GR3007470T3 (enExample) | ||
| JPS5411226A (en) | Disintegratable granule | |
| IE782515L (en) | Treating diarrhoea | |
| IE44704L (en) | ß-LACTAM ANTIBIOTIC | |
| IL79207A0 (en) | Pharmaceutical compositions containing terguide |